TSLA Q3 Earnings 10/21 will obviously beat earnings for Q2. However, estimates for Q3 are much higher than for Q2 so I don't expect as much of a parabolic rally like last time. Price Target for 10/21: $573.81 or about $2,869.05 pre-split Support moving forward: $399 - $415 Resistance #1 : ~$458-462 Key Resistance #2 (all time high): ~$500-503 Buy Zone:...
We now have a triple bottom on ZM 1) ~ 459.23 -> then sharp rebound upwards 2) ~ 457.78 -> then sharp rebound upwards 3) ~ 463.00 -> pending tomorrow's move Possible scenarios moving forward: A) If it breaks 263 and continues downtrend, next support to watch is around 445-450 B) If it rebounds from 263 (it seems like it already is in afterhours), price will meet...
Looking at MACD on 15m chart, VBIV looks like it might be on the verge of breaking out again. But first, it needs to break 3.91 and stay above. Short term PT: $4.75-5 Long term PT: $7.37-7.5 This is the only vaccine stock I am currently bullish on. Not only for their covid vaccine, but also Hep B, Glioblastoma, Medulloblastoma and Zika virus.